Primary hyperoxaluria (PH) is a rare inherited disorder characterized by abnormal calcium and oxalate metabolism, resulting in high levels of oxalate in the urine. Excessive excretion of oxalate can lead to the formation of oxalate kidney stones and can cause kidney damage, especially if left untreated. The underlying mechanism for the development of this pathology is related to defects in oxalate metabolism, which leads to its excessive production in the liver. There are different types of primary hyperoxaluria, of which types 1 and 2 are the most common, caused by mutations in the corresponding genes involved in oxalate metabolism.
History of the disease and interesting historical facts
The history of primary hyperoxaluria begins with its description in the mid-20th century. The first cases of the disease were registered in the 1950s, when doctors began to realize the connection between high levels of oxalate in the urine and the formation of kidney stones. In the 1980s, two main types of the disease were identified and described, which allowed us to better understand the mechanisms of its pathogenesis. One of the leading researchers in the field of PH was Dr. R. H. Steele, who made significant contributions to the study of the genetic aspects of the disease. In recent decades, significant progress has been made in the field of molecular diagnostics and treatment of primary hyperoxaluria, which has increased awareness among the medical community and patients.
Epidemiology
Primary hyperoxaluria has a rare prevalence in the population, with an incidence of approximately 1 case per 100,000 to 1 million people. However, geographic and racial differences vary across populations. For example, in some regions with specific ethnic groups, the incidence may be as high as 1 per 50,000. PH primarily manifests itself in childhood, but symptoms may also appear in later life. Studies of the epidemiology of primary hyperoxaluria suggest that lack of awareness of the disease may lead to an underestimation of its prevalence.
Genetic predisposition to this disease
Primary hyperoxaluria is a hereditary disorder transmitted in an autosomal recessive manner. The most common genes associated with PH are AGXT (type 1) and GRHPR (type 2), which encode enzymes involved in oxalate metabolism. Mutations in these genes result in insufficient activity of the corresponding enzymes and, thus, in excessive oxalate production. More than 200 different mutations associated with type 1 PH have been described, and many of them have different levels of severity and clinical manifestations.
Risk factors for the development of this disease
Risk factors for primary hyperoxaluria include both genetic and environmental factors. The most important genetic factors are associated with mutations in genes encoding enzymes involved in oxalate metabolism. In addition, some specific exogenous factors may contribute to the progression of the disease. These include:
- Unbalanced diet rich in calcium and oxalates (eg spinach, rhubarb).
- Other diseases accompanied by increased levels of oxalate in the urine.
- Some infections that affect calcium metabolism.
Certain drugs may also play a role in the development of hyperoxaluria by increasing oxalate levels in the urine.
Diagnosis of this disease
Diagnosis of primary hyperoxaluria is based on clinical symptoms and laboratory tests. The main symptoms include:
- Pain in the kidney area.
- Frequent acute attacks of renal colic.
- Blood in the urine (hematuria).
- Symptoms of kidney failure in advanced cases.
Laboratory studies suggest:
- Urine analysis for oxalate content.
- General urine analysis.
Radiological examinations such as ultrasound and CT scans of the kidneys may reveal the presence of stones. The differential diagnosis includes exclusion of secondary causes of hyperoxaluria such as malabsorption syndromes and rare medical conditions affecting calcium metabolism.
Treatment
Treatment of primary hyperoxaluria depends on the severity of the disease and includes both non-drug and drug methods. The main approaches are as follows:
- Changing your diet to reduce oxalate intake.
- Pharmacological treatment using vitamin B6 (pyridoxine) for patients with type 1 hypoxaluria.
- Surgical treatment to remove large oxalate stones and possible kidney transplantation in case of developing kidney failure.
Thus, the approach to treatment should be comprehensive and individually adapted to the patient’s health condition.
List of medications used to treat this disease
Your doctor may prescribe the following medications to treat primary hyperoxaluria:
- Pyridoxine (vitamin B6) - to reduce oxalate production in the liver.
- Thiazide diuretics - to reduce calcium levels in the urine.
- Magnesium - to bind oxalate in the intestines.
Adjustment of drug therapy should take place under the supervision of a physician, taking into account the individual characteristics of the patient.
Disease monitoring
Monitoring of primary hyperoxaluria includes regular testing for oxalate in urine and assessment of renal function. The prognosis of the disease depends on timely detection and adequate treatment. Otherwise, serious complications are possible, such as chronic renal failure, requiring replacement therapy. The main control stages:
- Periodic urine tests for oxalate levels.
- Evaluation of renal function using CT and ultrasound.
- Consultation with a nephrologist to determine the need for surgical intervention.
Age-related features of the disease
Primary hyperoxaluria can manifest itself at any age, but the greatest number of cases are registered in children and young people. In children, symptoms can appear at the age of 1-4 years, while in adults the disease can be diagnosed later due to a less pronounced clinical picture. It is important to consider that the presence of the disease in one of the parents increases the likelihood of its development in offspring.
Questions and Answers
- What is the cause of primary hyperoxaluria? Primary hyperoxaluria occurs due to genetic mutations that lead to a disruption of oxalate metabolism and its excessive production.
- Can I prevent primary hyperoxaluria? Prevention of this disease is impossible, as it is a genetic disorder. However, you can minimize the risk of stone formation by watching your diet.
- What are the main symptoms of the disease? Symptoms include low back pain, renal colic, hematuria and, in advanced cases, signs of renal failure.
- What is the treatment strategy for primary hyperoxaluria? Treatment includes dietary therapy, pharmacological agents and surgical interventions if necessary.
- What is the prognosis for primary hyperoxaluria? The prognosis varies depending on how promptly treatment is started and how effectively the disease is monitored.
